All fields · Otorhinolaryngology

JournalQ1· SCImago 2025

Journal of Clinical Oncology

ISSN 0732-183X

• Q1Quartile
• 4.00SJR
• 666h-index
• 38papers summarised

About this journal

Journal of Clinical Oncology is a Q1 journal by SCImago Journal Rank (2025 data), with an SJR of 4.00 and an h-index of 666. Most of its papers in the Pofolia pool fall under Otorhinolaryngology. Pofolia holds AI summaries of 38 paper(s) from this journal; the most cited is “Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and…” (5589 citations).

The quartile (Q1–Q4) is the journal's percentile position within its subject area by SCImago Journal Rank; Q1 is the top 25%. What is a Q1 journal?

Papers we summarise from this journal

• Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification2014 · 5589 citations
• Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update2013 · 4070 citations
• Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With <i>EGFR</i> Mutations2013 · 3204 citations
• Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair–Deficient Cancer: Results From the Phase II KEYNOTE-158 Study2019 · 2990 citations
• Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade2014 · 2783 citations
• Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index2013 · 2675 citations
• Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group2015 · 2189 citations
• Integration of Palliative Care Into Standard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline Update2017 · 2107 citations
• Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial2019 · 1824 citations
• International Society of Geriatric Oncology Consensus on Geriatric Assessment in Older Patients With Cancer2014 · 1811 citations
• Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group2014 · 1655 citations
• Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial2014 · 1632 citations
• Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma2012 · 1526 citations
• Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update2019 · 1485 citations
• Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology2018 · 1434 citations
• OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer2012 · 1376 citations
• Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 20142015 · 1374 citations
• Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)2018 · 1330 citations
• Worldwide Trends in Incidence Rates for Oral Cavity and Oropharyngeal Cancers2013 · 1296 citations
• Long-Term Results of RTOG 91-11: A Comparison of Three Nonsurgical Treatment Strategies to Preserve the Larynx in Patients With Locally Advanced Larynx Cancer2012 · 1283 citations
• Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial2020 · 1251 citations
• Epidemiology of Human Papillomavirus–Positive Head and Neck Squamous Cell Carcinoma2015 · 1241 citations
• Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 269512012 · 1227 citations
• Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia2012 · 1179 citations
• Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma2020 · 1174 citations
• Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 94022012 · 1165 citations
• Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 Study2019 · 1060 citations
• Management of Nasopharyngeal Carcinoma: Current Practice and Future Perspective2015 · 851 citations
• Randomized Phase III Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Stage III to IV Head and Neck Carcinoma: RTOG 05222014 · 833 citations
• Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update2013 · 709 citations

Journals in the same field

See every journal in the field →